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Abstract
We report the case of a 31-year-old woman with mediastinal
Castlemans disease of the hyaline vascular type. This large tumor
was safely resected after arterial embolization. We describe the
steps of this interventional procedure and discuss related necessary
precautions.
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Castlemans disease (CD) is a rare form of lymph node hyperplasia,
most commonly presenting as a solitary mediastinal mass. Com-
puted tomography (CT) and angiographic features of CD are
nonspecific [1] and a definite diagnosis is only based on histology
findings. The surgical approach is usually curative when the dis-
ease is unicentric [2], but it is frequently associated with profuse
bleeding. Only a few previous reports have suggested arterial
embolization in the preoperative management of CD [3, 4]. We
report a case of localized CD presenting as a voluminous mass in
the posterior mediastinum. Preoperative arterial embolization of
this tumor minimized intraoperative bleeding.
Case Report
A 31-year-old nonsmoking Asian woman with no medical history presented
with a dry cough for 6 months without any other symptoms. An abnormal
opacity in the posterior mediastinum was found on chest X-ray (Figs. 1A
and 1B). CT confirmed the presence of a 12-cm homogeneous, well-
delineated hypervascular right paravertebral mass of the posterior medias-
tinum (Fig. 1C). There was no evidence of pleural fluid or bone invasion.
Laboratory investigations were within the normal range. Fine-needle aspi-
ration or needle-core biopsy was not performed considering the risk of
bleeding from this hypervascular mass and because of its location.
A preoperative descending thoracic aortogram was obtained by means
of a 5F pigtail catheter (Cordis, Roden, The Netherlands), in order to
visualize the origin of the bronchial and extrabronchial arteries from the
aorta. A selective bronchial arteriography by means of a 5F steam-modified
Cobra catheter (Cordis, Roden, The Netherlands) supported the presence of
a hypervascular mediastinal mass. The lesion was exclusively supplied by
two arterial branches of a broncho-intercostal trunk originating from the
descending thoracic aorta; it drained into large uphill inferior esophageal
varices (Fig. 2). In a second step, embolization of these two feeding arteries
was performed, in order to minimize intraoperative bleeding. The superior
arterial branch, which supplied the superior and lateral portions of the mass,
was selectively catheterized with a 2.5F microcatheter (Tracker 18; Boston
Scientific, Cork, Ireland) and embolized by means of gelatin cross-linked
tris-acryl microspheres 500–750 lm in diameter (Embospheres; Biosphere
Medical, Roissy-Charles-de-Gaulle, France). Occlusion of the proximal
segment was completed by three 3-0 silk threads (Silkam; Aesculap,
Tuttlingen, Germany). The second arterial branch, which supplied the
inferior and medial portions of the mass, was superselectively catheterized
beyond the left bronchial artery and embolized in the same manner. Final
postembolization angiography showed complete occlusion of these feeding
arteries and the absence of vascularization of the mass (Fig. 2). After this
procedure, no adverse effects were observed.
A right anterior thoracotomy was performed 7 days after embolization.
Despite tight adhesions with the lung, the esophagus, and the subcarinal
area, the tumor could be completely removed. Blood loss during surgery did
not exceed 200 mL. A single chest tube was placed and removed on the
third postoperative day. The postoperative course was uneventful and the
patient was discharged on the fifth postoperative day. Thirty-six months
after surgery, she is doing well without any sign of recurrence of her
disease. The definite histological diagnosis was Castlemans disease of the
hyaline vascular type. Macroscopically, the tumor was surrounded by a
fibrous capsule and its internal organisation was similar to that of a lymph
node.
Discussion
Hypervascular mediastinal tumors are rare entities, benign or
malignant, occasionally found in children [5]. They include he-
mangiopericytomas [6], hemangioendothelioma [7], soft-tissue
angiosarcomas [8], pheochromocytomas [9], and some benign tu-
mors [10]; for practical purposes, arteriovenous malformations [11]
can also be included in this group. CD is another type of these
hypervascular tumors. First described in the mid-1950s [12], this
rare entity still causes diagnostic and therapeutic dilemmas and its
etiology is poorly understood (viruses and autoimmunity and
immunodeficiency states have been suggested). There are three
histological variants of CD: the hyaline vascular type, which ac-
counts for approximately 90% of cases, the plasma cell type, and
an intermediary ‘‘mixed’’ type. However, clinical significance is
determined by another classification, based on the distribution of
the disease. The localized form is generally benign and is cured by
surgical resection, whereas the multicentric form is more aggres-Correspondence to: Sylvain Terraz, MD; email: sylvain.terraz@hcuge.ch
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sive and tends to be accompanied by various immunologic
abnormalities and systemic constitutional symptoms. CD is usually
seen in the chest, but it has also been reported in the neck, retro-
peritoneum, pelvis, and wherever lymph nodes are present [2].
Hypervascularity of these tumors entails the propensity to bleed
and accounts for the difficulty in managing them from the start [13].
Spontaneous hemothoraces have been described [6]; biopsies, so
commonly resorted to in other solid thoracic tumors, are rightly
Fig. 1. Chest X-ray and CT of a 31-year-old woman presenting a
dry cough for 6 months. (A) Posteroanterior chest radiograph shows
a large, homogeneous, and well-marginated opacity (white arrows)
that causes mediastinal widening, but does not blur the right border
of the heart. (B) Lateral chest radiograph confirms its posterior
location in the mediastinum. (C) Contrast-enhanced chest CT
(mediastinal window) at the level of the right pulmonary artery shows
a homogeneous and hypervascular mass with regard to soft tissues.
The close relationship with the mass effect on the esophagus, right
main bronchus and right pulmonary artery is particularly well dem-
onstrated.
Fig. 2. Angiography prior to and following
embolization. (A) Arterial phase of aortography
shows the hypervascular mediastinal mass with
two feeding arteries coming from a broncho-
intercostal trunk: a superior and lateral branch
(black arrow) and an inferior and medial branch
(white arrow). (B) Venous phase of aortography
shows the hypervascular mass draining in large
uphill varices (black arrows). (C) Selective
arteriography of the superior branch after
embolization shows an occlusion of this vessel
with small intraluminal defects (black arrow)
corresponding to silk threads. (D) Selective
arteriography of the inferior branch after
embolization shows o an occlusion of this vessel
with preservation of mediastinal branches (black
arrow). After embolization, the mediastinal mass is
completely devascularized.
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feared and avoided [14]. Needless to say, the risk of bleeding is
even greater when surgery is contemplated. Although occasionally
reported successful [15, 16], thoracoscopy should be avoided in CD.
One case of hemangiopericytoma, in which diagnosis was not
known preoperatively, had to be operated on twice. Intractable
hemorrhage (2.1 L blood loss) occurred during the first operation,
which was only exploratory. Arterial embolization was successful
before the second surgical attempt—curative this time [17]. Indeed,
in all cases of tumors known or suspected to be hypervascular,
preoperative arteriography with embolization, which was first re-
ported in the 1970s [3], has made their management safer, partic-
ularly when surgery is warranted. This sophisticated technique,
however, is not devoid of risks and implies certain precautions.
Nonabsorbable microspheres might prevent the recurrence of
tumor hypervascularity due to recanalization of the embolized ar-
tery, as frequently observed with absorbable gelatin sponges. It is
essential to avoid material smaller than 325 lm in diameter, as it
can pass through bronchopulmonary anastomoses and lead to
pulmonary infarction or systemic arterial embolism (via anasto-
moses between bronchial arteries and pulmonary artery or vein,
respectively) [18]. By the same token, it is as important to avoid
embolic agents that cause distal occlusion to such an extent that
normal peripheral branches supplying the bronchi, esophagus,
aorta, and pulmonary artery might be equally occluded, leading to
obviously catastrophic complications [19]. For all of these reasons,
when bronchial artery embolization is contemplated, we recom-
mend the use of microparticles ranging in diameter from 350 to
700 lm [20]. Proximal vessel occlusion might preclude repeat
embolization after bronchial artery embolization for hemoptysis
[21]. In the case described, proximal embolization with inexpen-
sive silk threads was added to the procedure. This was done to
decrease the risk of new collateral vessels prior to surgery.
The most disastrous complication after bronchial artery embo-
lization is spinal cord ischemia due to the occlusion of spinal
arteries, which has been reported in 0–6.5% of cases [20–23].
Visualization of radicular branches on bronchial or intercostal
angiograms is not an absolute contraindication to embolization.
However, when the anterior spinal artery (artery of Adamkiewicz)
is identified at arteriography, embolization should not be per-
formed. Consequently, in order to decrease the risk of this dreaded
complication, it is of utmost importance to visualize all bronchial
and nonbronchial arteries prior to embolization.
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